Template:Genital terms

Genital System Terms (expand to view)

Note there are additional glossaries associated with spermatozoa, oocyte renal. androgens - male sex hormones, such as testosterone, or the more potent dihydrotestosterone (DHT, 5α-dihydrotestosterone, androstanolone, 5α-androstan-17β-ol-3-one), formed by the enzyme 5α-reductase. Dihydrotestosterone). androgen insensitivity syndrome - (AIS) Clinical term for a developmental abnormality affecting genital development, through a fetal tissue insensitivity to male hormones. anogenital distance - (AGD) A clinical measure of a parameter sexually dimorphic for genital development. This distance, from the posterior aspect of the scrotum to the anal verge, has been used as a marker for endocrine disruption in animal studies and may be shorter in infant males with genital anomalies. Recently been shown that infertile men possessed significantly shorter mean AGD. anorchia - (embryonic testicular regression, vanishing testis syndrome) Clinical term for the absence of testes in a 46,XY individual with a male phenotype. Rare abnormality with an incidence of about 1 in 20,000 male births, and occurs more frequently with cryptorchidism (1 in 177 cases). anti-mullerian hormone (AMH, Müllerian Inhibiting Substance, MIS) A secreted glycoprotein factor (transforming growth factor-beta, TGF-beta superfamily) that regulates gonadal and genital tract development. In the male embryo, the Sertoli cell secrete AMH and inhibit paramesonephric (Mullerian) duct development. In postnatal males, AMH increases during the first month, reaching peak level at 6 months of age, and then slowly declines during childhood falling to low levels in puberty. In reproductive age women, AMH is produced in the ovary by the granulosa cells surrounding preantral and small antral follicles and serum levels may reflect the remaining follicle cohort and decrease with age. Bardet-Biedl syndrome - (BBS) is an abnormality with triallelic inheritance and is characterized by a rangne of multisystem abnormalities (cone-rod dystrophy, truncal obesity, postaxial polydactyly, cognitive impairment, neural development, male hypogonadotrophic hypogonadism, complex female genitourinary malformations, and renal dysfunction). Bartholin gland - (greater vestibular gland) A pair of female external genital tract glands which secretes mucus to lubricate the vagina. The equivalent male gland is the Bulbourethral gland or Cowper's gland. bicornuate uterus - ("heart-shaped" uterus) Female uterus (internal genital tract) abnormality, where the paramesonephric ducts (Müllerian ducts) fail to completely fuse forming two separate body parts that fuse close to the opening into the vagina. broad ligament - Human female genital tract mesentery formed by a double fold of peritoneum that connects the uterus to the peritoneal floor and walls. Anatomically it has three parts: mesometrium (surrounding the uterus), mesosalpinx (surrounding the uterine tube) and mesovarium (surrounding the ovary). bulbourethral gland - (Cowper's gland) A male genital tract gland which secretes a small amount of a thick clear mucous fluid prior to ejaculation, the alkaline content apparently buffers acidity of the urethra. The equivalent female genital tract gland is the greater vestibular gland or Bartholin gland. cloaca - (cloacal cavity) The term describing the common cavity into which the intestinal, genital, and urinary tracts open in vertebrates. Located at the caudal end of the embryo it is located on the surface by the cloacal membrane. In many species this common cavity is later divided into a ventral urogenital region (urogenital sinus) and a dorsal gastrointestinal (rectal) region. cloacal membrane - Forms the external lower membrane limit (caudal end) of the early gastrointestinal tract (GIT). This membrane is formed during gastrulation by ectoderm and endoderm without a middle (intervening) layer of mesoderm. The membrane breaks down to form the initial "anal opening" of the gastrointestinal tract. The upper end of the gastrointestinal tract has a similar embryonic membrane, the buccopharyngeal membrane. clomiphene citrate - (CC) A fertility drug taken orally to promote the process of follicle/egg maturation in superovulation therapy. (CC) an anti-estrogen (MRL-41) therapy for WHO group II (eu-oestrogenic) infertility associated with polycystic ovary syndrome. Used for more than 40 years it is a simple, cheap treatment, with low side effects and yields a 25% live birth rate. Alternative therapeutics being considered are metformin, aromatase inhibitors and low-dose FSH. congenital adrenal hyperplasia - (CAH, adrenal virilism) Abnormality of the fetal adrenal cortex, alters cortisol and androgens with different effects dependent upon sex: in females masculization of the external genitalia; in males, disorder often unnoticed until postnatally. In both sexes, accelerated skeletal growth and sexual maturation is seen in late childhood. Caused by a deficiency or absence of the enzyme 21-hydroxylase in the adrenal cortex. Grouped with the Disorders of Sex Development (DSD). (More? congenital adrenal hyperplasia | Adrenal Development | Genital System - Abnormalities) 'Cowper's gland - (bulbourethral gland) A male genital tract gland which secretes a small amount of a thick clear mucous fluid prior to ejaculation, the alkaline content apparently buffers acidity of the urethra. The equivalent female genital tract gland is the greater vestibular gland or Bartholin gland. cryptorchid testes - (cryptorchidism) A male genital abnormality where the testes remain undescended in the abdominopelvic cavity or other non-scrotal locations. (More? Cryptorchidism | Genital - Male Development) greater vestibular gland (Bartholin gland) A pair of female external genital tract glands which secretes mucus to lubricate the vagina. The equivalent male gland is the Bulbourethral Gland or Cowper's Gland. Müllerian inhibiting substance - (MIS, anti-Müllerian hormone, AMH) A secreted glycoprotein factor (transforming growth factor-beta, TGF-beta superfamily) that regulates gonadal and genital tract development. In the male embryo, the Sertoli cell secrete AMH and inhibit paramesonephric (Müllerian) duct development. In postnatal males, AMH increases during the first month, reaching peak level at 6 months of age, and then slowly declines during childhood falling to low levels in puberty. In reproductive age women, AMH is produced in the ovary by the granulosa cells surrounding preantral and small antral follicles and serum levels may reflect the remaining follicle cohort and decrease with age.